Skip to Content

Posts tagged with "The Dark Side"

  • The Dark Side

    ACSNano on Problematic Papers

    The editorial board at ACSNano has come out with a statement on how they’d like problematic papers to be handled. This, the article most pointedly does not say, is surely a response to the controversy over a recent (ridiculously Photoshopped) paper that appeared in the journal. That one didn’t make anyone look good, and I… Read More
  • Infectious Diseases

    Holding Back Experimental Details, With Reason

    There’s a lot of worry these days about the reproducibility of scientific papers (a topic that’s come up here many times). And there’s reason to believe that the sharing of data, protocols, and materials is not going so well, either. . . . authors seem less willing to share these additional details about their study… Read More
  • The Dark Side

    A Leak at Lilly

    The Indianapolis Business Journal has reported that two ex-Lilly employees have been indicted on charges of stealing trade secrets: The indictment charges two Carmel residents, Guoqing Cao and Shuyu Li, with seven counts of theft and conspiracy to commit theft. It also describes the actions of a third man, referred to only as Individual #1… Read More
  • The Dark Side

    An Open Access Trash Heap

    Science magazine and writer John Bohannon have done us all a favor. There’s a long article out in the latest issue that details how he wrote up a terrible, ridiculous scientific manuscript, attached a made-up name to it under the aegis of a nonexistent institution, and sent this farrago off to over three hundred open-access… Read More
  • The Dark Side

    They’ll Fake the Journal if You’ll Fake the Papers

    The Economist has a disturbing article on the extent of academic publishing fraud in China. It’s disturbing that it goes on so much, and should be disturbing that it’s in The Economist: DISGUISED as employees of a gas company, a team of policemen burst into a flat in Beijing on September 1st. Two suspects inside… Read More
  • The Dark Side

    An Unknown Author With Someone Else’s Work. Why?

    Here’s a bizarre one: someone apparently faked up a bunch of author names and contact information, and published results (in Biochemical and Biophysical Research Communications) that they’re heard Bruce Spiegelman of Harvard talk about. The motive? Well. . .the only thing that makes sense is sheer vituperativeness, and even that doesn&# Read More
  • The Dark Side

    File Under “Nerve, Lots Of”

    From an editorial in Science written by the president and the vice-president of the European Research Council: Imagine sitting over a pile of applications submitted to one of the most prestigious funding agencies. Suddenly, what you read appears familiar—not only the idea, but its terminology and the methods proposed. You recognize entire sentenc… Read More
  • The Dark Side

    Exposing Faked Scientific Papers

    Chemistry World has a good article on the problem of shaky data in journal article, and the intersecting problem of what to do about it in the chemistry blogging world. Paul Bracher’s ChemBark is, naturally, a big focus of the piece, since he’s been highlighting some particularly egregious examples in the last couple of months… Read More
  • Business and Markets

    Now It’s Novartis’s Turn in China

    So reports FiercePharma, quoting a story in the 21st Century Business Herald and the Shanghai Daily. A former Novartis sales rep says that she was “ordered” to bribe doctors to meet sales quotas. As Tracy Staton at Fierce puts it: With Chinese authorities actively looking for any suggestion of corruption or bribery, we’re likely t… Read More
  • Business and Markets

    Sanofi in China

    Now Sanofi is tangled up in trouble in China. The last few days have brought news of a wide-ranging investigation into payments to hospitals and medical workers, similar to what GlaxoSmithKline has been accused of. And I don’t have much reason to doubt either story, because (as this BBC story details) payments of this sort… Read More